Glycanostics was selected as one of eight most innovative companies to participate in the MEDICAL FORGE Accelerator program 2023, which will facilitate and accelerate our entry to the German market. We are looking forward to bring our innovation to the patients, healthcare professionals and healthcare system in Germany very soon!